Co-beneldopa (Benserazide/levodopa) vs Botulinum toxin type A
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 5,399.4× as often as Botulinum toxin type A in June 2026 — 80,991 items versus 15 in England.
80,991items
Co-beneldopa (Benserazide/levodopa) · June 2026
NHSBSA Prescription Cost Analysis
15items
Botulinum toxin type A · June 2026
NHSBSA Prescription Cost Analysis
Figure 1. Co-beneldopa (Benserazide/levodopa) versus Botulinum toxin type A: national items dispensed by month
▬ Co-beneldopa (Benserazide/levodopa) · ╌ Botulinum toxin type A
Source: NHSBSA Prescription Cost Analysis, to June 2026
| Measure | Co-beneldopa (Benserazide/levodopa) | Botulinum toxin type A |
|---|---|---|
| Items, June 2026 | 80,991 | 15 |
| Items, last 12 months | 951,758 | 209 |
| Net ingredient cost, June 2026 | £997,047 | £2,670 |
See the full profile for Co-beneldopa (Benserazide/levodopa) or Botulinum toxin type A.